From: DASPfind: new efficient method to predict drug–target interactions
Method | AUC (%) | ‘Top 1’ (%) | ‘Top 2’ (%) | ‘Top 5’ (%) |
---|---|---|---|---|
Enzyme | ||||
NRWRH | 92.89 | 1.06 | 8.07 | 12.82 |
HGBI | 91.60 | 2.36 | 8.1 | 12.41 |
DT-Hybrid | 89.80 | 0 | 7.55 | 10.95 |
DASPfind | 92.91 | 52.08 | 55.29 | 62.74 |
Ion channels | ||||
NRWRH | 91.56 | 1.69 | 2.91 | 10.16 |
HGBI | 88.93 | 1.42 | 2.24 | 6.1 |
DT-Hybrid | 92 | 0 | 1.42 | 14.3 |
DASPfind | 90.68 | 32.72 | 35.09 | 46.54 |
GPCR | ||||
NRWRH | 84.93 | 2.52 | 11.50 | 40.94 |
HGBI | 91.29 | 5.83 | 12.28 | 31.5 |
DT-Hybrid | 83.87 | 0 | 6.93 | 31.65 |
DASPfind | 88.10 | 46.61 | 51.18 | 64.4 |
Nuclear receptors | ||||
NRWRH | 73.9 | 7.78 | 32.22 | 52.22 |
HGBI | 87.57 | 15.56 | 42.22 | 57.78 |
DT-Hybrid | 69.95 | 0 | 14.44 | 22.22 |
DASPfind | 85.27 | 53.3 | 65.5 | 77.7 |
HGBI_Dataset | ||||
NRWRH | 86.19 | 0 | 5.9 | 20.47 |
HGBI | 89.07 | 0 | 5.17 | 16.19 |
DT-Hybrid | 86.75 | 0 | 5.74 | 21.04 |
DASPfind | 89.61 | 28.30 | 33.32 | 42.51 |
DrugBank_Approved | ||||
NRWRH | 89.5 | 1.04 | 5.65 | 18.63 |
HGBI | 80.10 | 2.11 | 4.36 | 11.32 |
DT-Hybrid | 84.44 | 0.34 | 5.88 | 22.69 |
DASPfind | 88.84 | 27.82 | 32.89 | 48.56 |